Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-04-02ClinicalTrials.gov study NCT00006418
-
CLINICAL_TRIALS study record update · 2014-03-27An Open-label, Prospective, Non-Comparative Study to Evaluate Subjective Well-Being and Responses in Patients With Schizophrenia Who Had Switched to Paliperidone Extended-Release Tablets
-
CLINICAL_TRIALS study record update · 2014-03-26An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-26A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of JNJ-37822681 Administered Twice Daily in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-26Association of the Amisulpride Treatment Response in Patients With Schizophrenia With the Findings of Brain Structural Magnetic Resonance Imaging
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-03-26Treatment of Schizophrenia and Related Disorders in Children and Adolescents
-
CLINICAL_TRIALS study record update · 2014-03-21The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2014-03-20A Randomized, Double-Blind, Placebo-Controlled, Risperidone-Referenced, Parallel-Group, Adaptive-Design Study of the Efficacy, Safety, and Tolerability of Vabicaserin (SCA-136) in Subjects With Acute Exacerbations of Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-19Scale Validation of Prediction of Relapse and Rehospitalization Short Term in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-18A Double-Blind, Multiple Dose Titration Study to Investigate the Safety, Tolerability and Pharmacokinetics of Once Daily and Twice Daily Doses of JNJ-37822681 in Male and Female Patients With Stable Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-18Health Promotion and Fitness for Younger and Older Adults With SMI
-
CLINICAL_TRIALS study record update · 2014-03-14Clinical Trials to Compare the Pharmacokinetics Profile of DWCZP Tablet 100mg and Clozaril® Tablet 100mg After a Multi-dose Oral Administration in Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2014-03-13Glucose Regulation During Risperidone and Olanzapine Treatment
-
CLINICAL_TRIALS study record update · 2014-03-13Glucose Regulation During Ziprasidone Treatment
-
CLINICAL_TRIALS study record update · 2014-03-13Effects of Antipsychotic Medications on Energy Intake and Expenditure
-
CLINICAL_TRIALS study record update · 2014-03-11A Randomized, Open-label, Active-controlled Study to Evaluate Social Functioning of Long Acting Injectable Risperidone and Oral Risperidone in the Treatment of Subjects With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2014-03-11Neuroscience-Guided Remediation of Cognitive Deficits in Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-10A 6-month, Open Label, Prospective, Multicenter, International, Exploratory Study of a Transition to Flexibly Dosed Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated With Oral or Long-acting Injectable Antipsychotics
-
CLINICAL_TRIALS study record update · 2014-03-06An Open-label Prospective, Non-comparative Study to Evaluate the Subjective Experiences Upon Transition to Paliperidone Extended Release(ER) in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-05An Open Label, Prospective, Non-comparative Study to Evaluate Flexible Dose of Paliperidone Extended-Release and Clinical Response in the Treatment of Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-03-03Early Prediction of Clinical Response, Metabolic Change, and Pharmacokinetics in Taiwanese Patients With Schizophrenia Patients Treated by Paliperidone ER: an Open-Label Study
-
CLINICAL_TRIALS study record update · 2014-02-28Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Schizoaffective Disorders, Who is Receiving Psychiatric Home-care Treatment, When Switching From Typical Depot or Oral Antipsychotics to Long-acting Risperidone Microspheres
-
CLINICAL_TRIALS study record update · 2014-02-25Efficacy of Hierarchized Computer-assisted Cognitive Remediation Therapy in Schizophrenia
-
CLINICAL_TRIALS study record update · 2014-02-12Post Marketing Clinical Study of Aripiprazole in Patients With Schizophrenia - Effects on Glucose Metabolism-
-
CLINICAL_TRIALS study record update · 2014-02-12Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations